Sample Answer for NURS 6630 Therapy for Patients With Sleep or Wake Disorders Included After Question<\/strong><\/h2>\nFrom negative changes in mood to problems concentrating, sleep\/wake disorders can have a tremendous impact on patients\u2019 lives. When patients suffer from these disorders, they often seek medical care with the intent of receiving medications to manage symptoms. However, many of the medications used to treat sleep\/wake disorders may be addictive, making thorough patient assessments and close follow-up care essential. To prescribe appropriate therapies with patient safety<\/a> in mind, you must understand not only the pathophysiology of these disorders but also the pharmacologic agents used to treat them.<\/p>\nThis week, as you study therapies for individuals with sleep\/wake disorders, you examine the assessment and treatment of patients with these disorders. You also explore ethical and legal implications of these therapies.<\/p>\n
Learning Objectives<\/strong><\/h2>\nStudents will:<\/strong><\/h4>\n![\"NURS](\"https:\/\/nursingassignmentcrackers.com\/wp-content\/uploads\/2021\/10\/NURS-6630-Therapy-for-Patients-With-Sleep-or-Wake-Disorders-300x131.png\")
NURS 6630 Therapy for Patients With Sleep or Wake Disorders<\/figcaption><\/figure>\n\n- Synthesize concepts related to the psychopharmacologic treatment of patients<\/li>\n
- Assess patient factors and history to develop personalized therapy plans for patients with sleep\/wake disorders<\/li>\n
- Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring therapy for sleep\/wake disorders<\/li>\n
- Synthesize knowledge of providing care to patients presenting for sleep\/wake disorders<\/li>\n
- Analyze ethical and legal implications related to prescribing therapy for patients with sleep\/wake disorders<\/li>\n<\/ul>\n
Learning Resources<\/strong><\/h2>\nClick here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NURS 6630 Therapy for Patients With Sleep or Wake Disorders<\/strong><\/a><\/span><\/em><\/h3>\n <\/p>\n
Required Readings (click to expand\/reduce) <\/a><\/strong><\/p>\n <\/p>\n
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders <\/em>(5th ed.).<\/em>\u00a0https:\/\/doi.org\/10.1176\/appi.books.9780890425596<\/a><\/p>\nFernandez-Mendoza, J., & Vgontzas, A. N. (2013). Insomnia and its impact on physical and mental health. Current Psychiatry Reports, 15<\/em>(12), 418. https:\/\/doi.org\/10.1007\/s11920-012-0418-8<\/a><\/p>\nLevenson, J. C., Kay, D. B., & Buysse, D. J. (2015). The pathophysiology of insomnia. Chest, 147<\/em>(4), 1179\u20131192. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4388122\/<\/a><\/p>\nMorgenthaler, T. I., Kapur, V. K., Brown, T. M., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Friedman, L., Maganti, R., Owens, J., Pancer, J., & Zak, R. (2007). Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. SLEEP, 30<\/em>(12), 1705\u20131711. https:\/\/j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com\/wp-content\/uploads\/2017\/07\/PP_Narcolepsy.pdf<\/a><\/p>\nMorgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B, Brown, T. M., Coleman, J., Friedman, L., Kapur, V. K., Lee-Chiong, T., Pancer, J., & Swick, T. J. (2006). Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. SLEEP<\/em>, 29<\/em>(1), 1277\u20131281.\u00a0https:\/\/j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com\/wp-content\/uploads\/2017\/07\/PP_NightWakingsChildren.pdf<\/a><\/p>\nSateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13<\/em>(2), 307\u2013349. https:\/\/jcsm.aasm.org\/doi\/pdf\/10.5664\/jcsm.6470<\/a><\/p>\nWinkleman, J. W. (2015). Insomnia disorder. The New England Journal of Medicine, 373<\/em>(15), 1437\u20131444. https:\/\/doi.org\/10.1056\/NEJMcp1412740<\/a><\/p>\n <\/p>\n
Medication Resources (click to expand\/reduce) <\/a><\/strong><\/p>\n <\/p>\n
U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs<\/em>. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm<\/a><\/p>\n <\/p>\n
Note:\u00a0<\/strong>To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.<\/p>\n
This week, as you study therapies for individuals with sleep\/wake disorders, you examine the assessment and treatment of patients with these disorders. You also explore ethical and legal implications of these therapies.<\/p>\n
Learning Objectives<\/strong><\/h2>\nStudents will:<\/strong><\/h4>\nNURS 6630 Therapy for Patients With Sleep or Wake Disorders<\/figcaption><\/figure>\n\n- Synthesize concepts related to the psychopharmacologic treatment of patients<\/li>\n
- Assess patient factors and history to develop personalized therapy plans for patients with sleep\/wake disorders<\/li>\n
- Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring therapy for sleep\/wake disorders<\/li>\n
- Synthesize knowledge of providing care to patients presenting for sleep\/wake disorders<\/li>\n
- Analyze ethical and legal implications related to prescribing therapy for patients with sleep\/wake disorders<\/li>\n<\/ul>\n
Learning Resources<\/strong><\/h2>\nClick here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NURS 6630 Therapy for Patients With Sleep or Wake Disorders<\/strong><\/a><\/span><\/em><\/h3>\n <\/p>\n
Required Readings (click to expand\/reduce) <\/a><\/strong><\/p>\n <\/p>\n
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders <\/em>(5th ed.).<\/em>\u00a0https:\/\/doi.org\/10.1176\/appi.books.9780890425596<\/a><\/p>\nFernandez-Mendoza, J., & Vgontzas, A. N. (2013). Insomnia and its impact on physical and mental health. Current Psychiatry Reports, 15<\/em>(12), 418. https:\/\/doi.org\/10.1007\/s11920-012-0418-8<\/a><\/p>\nLevenson, J. C., Kay, D. B., & Buysse, D. J. (2015). The pathophysiology of insomnia. Chest, 147<\/em>(4), 1179\u20131192. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4388122\/<\/a><\/p>\nMorgenthaler, T. I., Kapur, V. K., Brown, T. M., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Friedman, L., Maganti, R., Owens, J., Pancer, J., & Zak, R. (2007). Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. SLEEP, 30<\/em>(12), 1705\u20131711. https:\/\/j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com\/wp-content\/uploads\/2017\/07\/PP_Narcolepsy.pdf<\/a><\/p>\nMorgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B, Brown, T. M., Coleman, J., Friedman, L., Kapur, V. K., Lee-Chiong, T., Pancer, J., & Swick, T. J. (2006). Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. SLEEP<\/em>, 29<\/em>(1), 1277\u20131281.\u00a0https:\/\/j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com\/wp-content\/uploads\/2017\/07\/PP_NightWakingsChildren.pdf<\/a><\/p>\nSateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13<\/em>(2), 307\u2013349. https:\/\/jcsm.aasm.org\/doi\/pdf\/10.5664\/jcsm.6470<\/a><\/p>\nWinkleman, J. W. (2015). Insomnia disorder. The New England Journal of Medicine, 373<\/em>(15), 1437\u20131444. https:\/\/doi.org\/10.1056\/NEJMcp1412740<\/a><\/p>\n <\/p>\n
Medication Resources (click to expand\/reduce) <\/a><\/strong><\/p>\n <\/p>\n
U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs<\/em>. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm<\/a><\/p>\n <\/p>\n
Note:\u00a0<\/strong>To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.<\/p>\n
- \n
- Synthesize concepts related to the psychopharmacologic treatment of patients<\/li>\n
- Assess patient factors and history to develop personalized therapy plans for patients with sleep\/wake disorders<\/li>\n
- Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring therapy for sleep\/wake disorders<\/li>\n
- Synthesize knowledge of providing care to patients presenting for sleep\/wake disorders<\/li>\n
- Analyze ethical and legal implications related to prescribing therapy for patients with sleep\/wake disorders<\/li>\n<\/ul>\n
Learning Resources<\/strong><\/h2>\n
Click here to ORDER an A++ paper from our MASTERS and DOCTORATE WRITERS: NURS 6630 Therapy for Patients With Sleep or Wake Disorders<\/strong><\/a><\/span><\/em><\/h3>\n
<\/p>\n
Required Readings (click to expand\/reduce) <\/a><\/strong><\/p>\n
<\/p>\n
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders <\/em>(5th ed.).<\/em>\u00a0https:\/\/doi.org\/10.1176\/appi.books.9780890425596<\/a><\/p>\n
Fernandez-Mendoza, J., & Vgontzas, A. N. (2013). Insomnia and its impact on physical and mental health. Current Psychiatry Reports, 15<\/em>(12), 418. https:\/\/doi.org\/10.1007\/s11920-012-0418-8<\/a><\/p>\n
Levenson, J. C., Kay, D. B., & Buysse, D. J. (2015). The pathophysiology of insomnia. Chest, 147<\/em>(4), 1179\u20131192. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4388122\/<\/a><\/p>\n
Morgenthaler, T. I., Kapur, V. K., Brown, T. M., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Friedman, L., Maganti, R., Owens, J., Pancer, J., & Zak, R. (2007). Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. SLEEP, 30<\/em>(12), 1705\u20131711. https:\/\/j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com\/wp-content\/uploads\/2017\/07\/PP_Narcolepsy.pdf<\/a><\/p>\n
Morgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B, Brown, T. M., Coleman, J., Friedman, L., Kapur, V. K., Lee-Chiong, T., Pancer, J., & Swick, T. J. (2006). Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. SLEEP<\/em>, 29<\/em>(1), 1277\u20131281.\u00a0https:\/\/j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com\/wp-content\/uploads\/2017\/07\/PP_NightWakingsChildren.pdf<\/a><\/p>\n
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13<\/em>(2), 307\u2013349. https:\/\/jcsm.aasm.org\/doi\/pdf\/10.5664\/jcsm.6470<\/a><\/p>\n
Winkleman, J. W. (2015). Insomnia disorder. The New England Journal of Medicine, 373<\/em>(15), 1437\u20131444. https:\/\/doi.org\/10.1056\/NEJMcp1412740<\/a><\/p>\n
<\/p>\n
Medication Resources (click to expand\/reduce) <\/a><\/strong><\/p>\n
<\/p>\n
U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs<\/em>. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm<\/a><\/p>\n
<\/p>\n
Note:\u00a0<\/strong>To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.<\/p>\n